The Gorlin Syndrome Group UK are proud to work in partnership with the Gorlin Syndrome Alliance in the USA, PellePharm and LEO Pharma to advance the development and research of new treatments for Gorlin Syndrome. We call it Partnership4Change. Watch the video to learn more.
The partnership have been working in collaboration over many months to get to this stage in the Patidegib trial. Our work will continue and we look forward to see the emerging data from the trial.
The Phase III trial is now closed for screening on the Patidegib Phase III trial 150 patients have been recruited, are undergoing/undergone screening with a view to commencing the trial.